monumental-1 update: talquetamab in r/r multiple myeloma
Published 1 year ago • 306 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
2:41
monumental-1: talquetamab for multiple myeloma
-
4:44
investigating immune dynamics in multiple myeloma treated with talquetamab monotherapy
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
4:16
what is the monoclonal antibody talvey™ (talquetamab)?
-
15:43
elranatamab - upcoming myeloma therapy
-
1:18
the talisman study: prophylactic treatment for talquetamab-related oral toxicity in myeloma
-
4:15
bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab
-
4:17
evaluating the safety and efficacy of elranatamab in multiple myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
1:41
innovative treatment strategies for multiple myeloma
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
1:46
changes in the myeloma treatment paradigm
-
1:16
insights into the magnetismm-4 trial
-
2:58
monumental-2: talquetamab plus pomalidomide in r/r multiple myeloma
-
2:15
novel immunotherapies for the treatment of multiple myeloma
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma